|
1
|
Saif MW: Targeted agents for adjuvant
therapy of colon cancer. Clin Colorectal Cancer. 6:46–51. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Raynal P and Pollard HB: Annexins: the
problem of assessing the biological role for a gene family of
multifunctional calcium- and phospholipid-binding proteins. Biochim
Biophys Acta. 1197:63–93. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gerke V and Moss SE: Annexins: from
structure to function. Physiol Rev. 82:331–371. 2002.PubMed/NCBI
|
|
4
|
Gerke V, Creutz CE and Moss SE: Annexins:
linking Ca2+ signalling to membrane dynamics. Nat Rev
Mol Cell Biol. 6:449–461. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bai XF, Ni XG, Zhao P, et al:
Overexpression of annexin 1 in pancreatic cancer and its clinical
significance. World J Gastroenterol. 10:1466–1470. 2004.PubMed/NCBI
|
|
6
|
Zimmermann U, Woenckhaus C, Teller S, et
al: Expression of annexin AI in conventional renal cell carcinoma
(CRCC) correlates with tumour stage, Fuhrman grade, amount of
eosinophilic cells and clinical outcome. Histol Histopathol.
22:527–534. 2007.
|
|
7
|
Chen R, Brentnall TA, Pan S, et al:
Quantitative proteomics analysis reveals that proteins
differentially expressed in chronic pancreatitis are also
frequently involved in pancreatic cancer. Mol Cell Proteomics.
6:1331–1342. 2007. View Article : Google Scholar
|
|
8
|
Esposito I, Penzel R, Chaib-Harrireche M,
et al: Tenascin C and annexin II expression in the process of
pancreatic carcinogenesis. J Pathol. 208:673–685. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bae SM, Lee CH, Cho YL, et al:
Two-dimensional gel analysis of protein expression profile in
squamous cervical cancer patients. Gynecol Oncol. 99:26–35. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Domoto T, Miyama Y, Suzuki H, et al:
Evaluation of S100A10, annexin II and B-FABP expression as markers
for renal cell carcinoma. Cancer Sci. 98:77–82. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wamunyokoli FW, Bonome T, Lee JY, et al:
Expression profiling of mucinous tumors of the ovary identifies
genes of clinicopathologic importance. Clin Cancer Res. 12:690–700.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Köllermann J, Schlomm T, Bang H, et al:
Expression and prognostic relevance of Annexin A3 in prostate
cancer. Eur Urol. 54:1314–1323. 2008.
|
|
13
|
Yan X, Yin J, Yao H, Mao N, Yang Y and Pan
L: Increased expression of Annexin A3 is a mechanism of platinum
resistance in ovarian cancer. Cancer Res. 70:1616–1624. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tan Y, Meng HP, Teng FM, et al: Effect of
miRNA interference to AnnexinA3 gene on growth of human gallbladder
cancer cells. Chin Hepatobiliary Surg. 16:853–856. 2010.(In
Chinese).
|
|
15
|
Katsuta M, Miyashita M, Makino H, et al:
Correlation of hypoxia inducible factor-1alpha with lymphatic
metastasis via vascular endothelial growth factor-C in human
esophageal cancer. Exp Mol Pathol. 78:123–130. 2005. View Article : Google Scholar
|
|
16
|
Kimura S, Kitadai Y, Tanaka S, et al:
Expression of hypoxia-inducible factor (HIF)-1alpha is associated
with vascular endothelial growth factor expression and tumour
angiogenesis in human oesophageal squamous cell carcinoma. Eur J
Cancer. 40:1904–1912. 2004. View Article : Google Scholar
|
|
17
|
Kyzas PA, Stefanou D, Batistatou A and
Agnantis NJ: Prognostic significance of VEGF immunohistochemical
expression and tumor angiogenesis in head and neck squamous cell
carcinoma. J Cancer Res Clin Oncol. 131:624–630. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shibaji T, Nagao M, Ikeda N, et al:
Prognostic significance of HIF-1 alpha overexpression in human
pancreatic cancer. Anticancer Res. 23:4721–4727. 2003.PubMed/NCBI
|
|
19
|
Park JE, Lee DH, Lee JA, et al: Annexin A3
is a potential angiogenic mediator. Biochim Biophys Res Com.
337:1283–1287. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu YF, Xiao ZQ, Li MX, et al:
Quantitative proteome analysis reveals Annexin A3 as a novel
biomarker in lung adenocarcinoma. J Pathol. 217:54–64. 2009.
View Article : Google Scholar : PubMed/NCBI
|
